Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.


Copyright West LLC. Minimum 15 minutes delayed.

Recent News
Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Read More
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Dec. 11, 2018-- Ra Pharmaceuticals, Inc. (Nasdaq: RARX) (“Ra Pharma”) today announced the pricing of an underwritten public offering of 8,387,097 shares of its common stock, at a public offering price of $15.50 per share, before underwriting discounts and
Upcoming Event
There are currently no events scheduled.

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridge Park Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061